Education
About Us
Working with TipRanks
Follow Us
Pharmadrug Inc. (TSE:PHRX)
:PHRX
Total Valuation
Pharmadrug has a market cap or net worth of C$1.08M. The enterprise value is C$6.67M.
Market CapC$1.08M
Enterprise ValueC$6.67M
Share Statistics
Pharmadrug has 108,234,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding108,234,380
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmadrug’s return on equity (ROE) is 7.74 and return on invested capital (ROIC) is -412.08%.
Return on Equity (ROE)7.74
Return on Assets (ROA)-11.01
Return on Invested Capital (ROIC)-412.08%
Return on Capital Employed (ROCE)0.91
Revenue Per Employee0.00
Profits Per Employee-1.47M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pharmadrug is -0.21. Pharmadrug’s PEG ratio is 0.04.
PE Ratio-0.21
PS Ratio0.00
PB Ratio1.22
Price to Fair Value-1.66
Price to FCF-7.96
Price to Operating Cash Flow-8.06
PEG Ratio0.04
Income Statement
In the last 12 months, Pharmadrug had revenue of 0.00 and earned -13.20M in profits. Earnings per share was -0.23.
Revenue0.00
Gross Profit-26.22K
Operating Income-1.33M
Pretax Income-14.27M
Net Income-13.20M
EBITDA-1.33M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was -1.13M and capital expenditures 0.00, giving a free cash flow of -1.13M billion.
Operating Cash Flow-1.13M
Free Cash Flow-1.13M
Free Cash Flow per Share-0.01
Dividends & Yields
Pharmadrug pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.32
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)47.13
Average Volume (3m)283.02K
Important Dates
Pharmadrug upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMay 23, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Pharmadrug as a current ratio of 0.22, with Debt / Equity ratio of 12.06%
Current Ratio0.22
Quick Ratio0.22
Debt to Market Cap0.63
Net Debt to EBITDA-1.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharmadrug has paid -1.01M in taxes.
Income Tax-1.01M
Effective Tax Rate0.07
Enterprise Valuation
Pharmadrug EV to EBITDA ratio is -3.13, with an EV/FCF ratio of -6.22.
EV to Sales0.00
EV to EBITDA-3.13
EV to Free Cash Flow-6.22
EV to Operating Cash Flow-6.22
Balance Sheet
Pharmadrug has C$128.12K in cash and marketable securities with C$1.40M in debt, giving a net cash position of C$1.27M billion.
Cash & Marketable SecuritiesC$128.12K
Total DebtC$1.40M
Net CashC$1.27M
Net Cash Per ShareC$0.01
Tangible Book Value Per Share-C$0.04
Margins
Gross margin is 26.63%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin26.63%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Pharmadrug is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-2291.11%